Wikidata entity: Q834280
C₁₃H₁₈ClNO (P274)
Quantities
| P4250 | defined daily dose | 0.3 |
| P2067 | mass | 239.107692 |
| P3780 | active ingredient in | ... | Q47521061 (Aplenzin) | Aplenzin |
| P3780 | active ingredient in | ... | Q47521291 (Wellbutrin) | Wellbutrin |
| P3780 | active ingredient in | ... | Q47521628 (Forfivo) | Forfivo |
| P3780 | active ingredient in | ... | Q47522363 (Zyban) | Zyban |
| P3780 | active ingredient in | ... | Q48828815 (Buproban) | Buproban |
| P3780 | active ingredient in | ... | Q48829143 (Budeprion) | Budeprion |
| P233 | canonical SMILES | String | CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C | ??? |
| P373 | Commons category | String | Bupropion | ??? |
| P1889 | different from | ... | Q407721 (buprenorphine) | buprenorphine |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P366 | has use | ... | Q12140 (medication) | medication |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Bupropion-3d-CPK.png | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83284310 (LiverTox toxicity likelihood category C) | LiverTox toxicity likelihood category C |
| P2175 | medical condition treated | ... | Q42844 (major depressive disorder) | major depressive disorder |
| P2175 | medical condition treated | ... | Q181923 (attention deficit hyperactivity disorder) | attention deficit hyperactivity disorder |
| P2175 | medical condition treated | ... | Q154430 (anxiety) | anxiety |
| P2175 | medical condition treated | ... | Q18553444 (nicotine dependence) | nicotine dependence |
| P2175 | medical condition treated | ... | Q19000444 (neurotic disorder) | neurotic disorder |
| P129 | physically interacts with | ... | Q2271947 (solute carrier family 6 member 3) | solute carrier family 6 member 3 |
| P129 | physically interacts with | ... | Q7050954 (Solute carrier family 6 member 2) | Solute carrier family 6 member 2 |
| P3489 | pregnancy category | ... | Q3679233 (Australian pregnancy category B2) | Australian pregnancy category B2 |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P636 | route of administration | ... | Q640448 (intravenous infusion and defusion) | intravenous infusion and defusion |
| P636 | route of administration | ... | Q285166 (oral administration) | oral administration |
| P636 | route of administration | ... | Q4010888 (inhalation administration) | inhalation administration |
| P769 | significant drug interaction | ... | Q58397 (amitriptyline) | amitriptyline |
| P769 | significant drug interaction | ... | Q58713 (clomipramine) | clomipramine |
| P769 | significant drug interaction | ... | Q218842 (zolpidem) | zolpidem |
| P769 | significant drug interaction | ... | Q58396 (imipramine) | imipramine |
| P769 | significant drug interaction | ... | Q423498 (trimipramine) | trimipramine |
| P769 | significant drug interaction | ... | Q898407 (venlafaxine) | venlafaxine |
| P769 | significant drug interaction | ... | Q1747559 (phenelzine) | phenelzine |
| P769 | significant drug interaction | ... | Q71704041 ((E/Z)-doxepin) | (E/Z)-doxepin |
| P769 | significant drug interaction | ... | Q408471 (paroxetine) | paroxetine |
| P769 | significant drug interaction | ... | Q47495783 ((−)-selegiline) | (−)-selegiline |
| P769 | significant drug interaction | ... | Q411377 (linezolid) | linezolid |
| P769 | significant drug interaction | ... | Q411932 ((S)-duloxetine) | (S)-duloxetine |
| P769 | significant drug interaction | ... | Q420685 (rasagiline) | rasagiline |
| P769 | significant drug interaction | ... | Q421934 (moclobemide) | moclobemide |
| P769 | significant drug interaction | ... | Q422244 (fluoxetine) | fluoxetine |
| P9989 | stylized name | String | buPROPion | ??? |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q76560 (antidepressant) | antidepressant |
| P2868 | subject has role | ... | Q899647 (dopamine reuptake inhibitor) | dopamine reuptake inhibitor |
| P2868 | subject has role | ... | Q899668 (adrenergic uptake inhibitors) | adrenergic uptake inhibitors |
| P2868 | subject has role | ... | Q334477 (selective serotonin reuptake inhibitor) | selective serotonin reuptake inhibitor |
| P2868 | subject has role | ... | Q50430508 (cytochrome P-450 CYP2D6 inhibitors) | cytochrome P-450 CYP2D6 inhibitors |
| P2868 | subject has role | ... | Q50430246 (second-generation antidepressive agents) | second-generation antidepressive agents |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | bupropion | ??? |
Why not click here or view trends?
log id: 1637754